These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 25998890)
1. Comparison of Everolimus- versus Sirolimus-eluting stents in the provisional Bifurcation stenting guided by intravascular ultrasound: mid-term results of the J-REVERSE registry. Murasato Y; Kinoshita Y; Yamawaki M; Shinke T; Otake H; Takeda Y; Fujii K; Yamada S; Shimada Y; Yamashita T; Yumoto K Cardiovasc Interv Ther; 2016 Jan; 31(1):1-12. PubMed ID: 25998890 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of kissing balloon inflation after provisional stenting in bifurcation lesions guided by intravascular ultrasound: short and midterm results of the J-REVERSE registry. Murasato Y; Kinoshita Y; Yamawaki M; Shinke T; Otake H; Takeda Y; Fujii K; Yamada S; Shimada Y; Yamashita T; Yumoto K; Fujino Y; EuroIntervention; 2016 Feb; 11(11):e1237-48. PubMed ID: 26865441 [TBL] [Abstract][Full Text] [Related]
3. A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial). Maeng M; Baranauskas A; Christiansen EH; Kaltoft A; Holm NR; Krusell LR; Ravkilde J; Tilsted HH; Thayssen P; Jensen LO Catheter Cardiovasc Interv; 2015 Dec; 86(7):1161-7. PubMed ID: 25640050 [TBL] [Abstract][Full Text] [Related]
4. Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent Trial (RESET). Kimura T; Morimoto T; Natsuaki M; Shiomi H; Igarashi K; Kadota K; Tanabe K; Morino Y; Akasaka T; Takatsu Y; Nishikawa H; Yamamoto Y; Nakagawa Y; Hayashi Y; Iwabuchi M; Umeda H; Kawai K; Okada H; Kimura K; Simonton CA; Kozuma K; Circulation; 2012 Sep; 126(10):1225-36. PubMed ID: 22824435 [TBL] [Abstract][Full Text] [Related]
5. Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach. Burzotta F; Trani C; Todaro D; Mariani L; Talarico GP; Tommasino A; Giammarinaro M; Niccoli G; Porto I; Leone AM; Mongiardo R; Mazzari MA; Schiavoni G; Crea F JACC Cardiovasc Interv; 2011 Mar; 4(3):327-35. PubMed ID: 21435612 [TBL] [Abstract][Full Text] [Related]
6. Long-term clinical outcomes after everolimus- and sirolimus-eluting coronary stent implantation: final 3-year follow-up of the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial. Shiomi H; Kozuma K; Morimoto T; Igarashi K; Kadota K; Tanabe K; Morino Y; Akasaka T; Abe M; Suwa S; Muramatsu T; Kobayashi M; Dai K; Nakao K; Uematsu M; Tarutani Y; Fujii K; Simonton CA; Kimura T; Circ Cardiovasc Interv; 2014 Jun; 7(3):343-54. PubMed ID: 24803436 [TBL] [Abstract][Full Text] [Related]
7. Comparative assessment of mammalian target of rapamycin inhibitor-eluting stents in the treatment of coronary artery bifurcation lesions: the CASTOR-Bifurcation registry. Sgueglia GA; Burzotta F; Trani C; Todaro D; Talarico GP; Niccoli G; Porto I; Leone AM; Coluccia V; Mazzari MA; Mongiardo R; Schiavoni G; Crea F Catheter Cardiovasc Interv; 2011 Mar; 77(4):503-9. PubMed ID: 20602477 [TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosis. Ota H; Mahmoudi M; Kitabata H; Torguson R; Chen F; Satler LF; Suddath WO; Pichard AD; Waksman R Cardiovasc Revasc Med; 2015 Mar; 16(2):84-9. PubMed ID: 25870152 [TBL] [Abstract][Full Text] [Related]
9. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials. Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661 [TBL] [Abstract][Full Text] [Related]
10. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry. Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K; JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178 [TBL] [Abstract][Full Text] [Related]
11. A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial. Gao RL; Xu B; Lansky AJ; Yang YJ; Ma CS; Han YL; Chen SL; Li H; Zhang RY; Fu GS; Yuan ZY; Jiang H; Huo Y; Li W; Zhang YJ; Leon MB; EuroIntervention; 2013 May; 9(1):75-83. PubMed ID: 23685298 [TBL] [Abstract][Full Text] [Related]
12. Randomized Comparison of FFR-Guided and Angiography-Guided Provisional Stenting of True Coronary Bifurcation Lesions: The DKCRUSH-VI Trial (Double Kissing Crush Versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions VI). Chen SL; Ye F; Zhang JJ; Xu T; Tian NL; Liu ZZ; Lin S; Shan SJ; Ge Z; You W; Liu YQ; Qian XS; Li F; Yang S; Kwan TW; Xu B; Stone GW JACC Cardiovasc Interv; 2015 Apr; 8(4):536-46. PubMed ID: 25819187 [TBL] [Abstract][Full Text] [Related]
13. One-year clinical outcomes of everolimus- versus sirolimus-eluting stents in patients with acute myocardial infarction. Chen KY; Rha SW; Wang L; Li YJ; Li GP; Choi CU; Park CG; Seo HS; Oh DJ; Jeong MH; Ahn YK; Hong TJ; Kim YJ; Chae SC; Hur SH; Seong IW; Chae JK; Cho MC; Bae JH; Choi DH; Jang YS; Chae IH; Kim HS; Kim CJ; Yoon JH; Ahn TH; Chung WS; Seung KB; Park SJ; Int J Cardiol; 2014 Oct; 176(3):583-8. PubMed ID: 25305704 [TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial. Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Stanco G; Rosato G; Suryapranata H; De Luca G JACC Cardiovasc Interv; 2014 Aug; 7(8):849-56. PubMed ID: 25147029 [TBL] [Abstract][Full Text] [Related]
15. Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial. Wiemer M; Serruys PW; Miquel-Hebert K; Neumann FJ; Piek JJ; Grube E; Haase J; Thuesen L; Hamm C Catheter Cardiovasc Interv; 2010 Jun; 75(7):997-1003. PubMed ID: 20517959 [TBL] [Abstract][Full Text] [Related]
16. Serial intravascular ultrasound analysis of complex bifurcation coronary lesions treated with the Tryton Bifurcation Stent in conjunction with an everolimus-eluting stent: IUVANT (Intravascular Ultrasound Evaluation of Tryton Stent) study. Bartorelli AL; Trabattoni D; Almonacid A; Fabbiocchi F; Montorsi P; Galli S; Grancini L; Ravagnani P; Mintz GS; Kaplan AV; Popma JJ; Maehara A Catheter Cardiovasc Interv; 2015 Mar; 85(4):544-53. PubMed ID: 25115944 [TBL] [Abstract][Full Text] [Related]
17. Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial. Park KW; Chae IH; Lim DS; Han KR; Yang HM; Lee HY; Kang HJ; Koo BK; Ahn T; Yoon JH; Jeong MH; Hong TJ; Chung WY; Jo SH; Choi YJ; Hur SH; Kwon HM; Jeon DW; Kim BO; Park SH; Lee NH; Jeon HK; Gwon HC; Jang YS; Kim HS J Am Coll Cardiol; 2011 Oct; 58(18):1844-54. PubMed ID: 22018294 [TBL] [Abstract][Full Text] [Related]
18. Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial. Claessen BE; Beijk MA; Legrand V; Ruzyllo W; Manari A; Varenne O; Suttorp MJ; Tijssen JG; Miquel-Hebert K; Veldhof S; Henriques JP; Serruys PW; Piek JJ Circ Cardiovasc Interv; 2009 Aug; 2(4):339-47. PubMed ID: 20031737 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of everolimus-eluting stent implantation in patients with small coronary arteries (≤2.5 mm): outcomes of 3-year clinical follow-up. Yano H; Horinaka S; Ishikawa M; Ishimitsu T Heart Vessels; 2017 Jul; 32(7):796-803. PubMed ID: 28025695 [TBL] [Abstract][Full Text] [Related]
20. Sirolimus- versus paclitaxel-eluting stents for the treatment of coronary bifurcations results: from the COBIS (Coronary Bifurcation Stenting) Registry. Song YB; Hahn JY; Choi SH; Choi JH; Lee SH; Jeong MH; Kim HS; Seong IW; Yang JY; Rha SW; Jang Y; Yoon JH; Tahk SJ; Seung KB; Park SJ; Gwon HC J Am Coll Cardiol; 2010 Apr; 55(16):1743-50. PubMed ID: 20394879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]